Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer
about
Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in CancerHijacking the Hexosamine Biosynthetic Pathway to Promote EMT-Mediated Neoplastic PhenotypesGlycoproteins and glycoproteomics in pancreatic cancerA Knowledge-Based System for Display and Prediction of O-Glycosylation Network Behaviour in Response to Enzyme KnockoutsCAZyChip: dynamic assessment of exploration of glycoside hydrolases in microbial ecosystems.N- and O-Glycomics from Minor Amounts of Formalin-Fixed, Paraffin-Embedded Tissue Samples.Chemical Synthesis of GM2 Glycans, Bioconjugation with Bacteriophage Qβ, and the Induction of Anticancer Antibodies.Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer.High expression of GFAT1 predicts poor prognosis in patients with pancreatic cancer.Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells.N-acetylgalactosaminyltransferases in cancer.High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinoma.Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer.Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer.Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathwayTool for Rapid Analysis of Glycopeptide by Permethylation via One-Pot Site Mapping and Glycan Analysis.Drug resistance related to aberrant glycosylation in colorectal cancer.Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression.Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis.Beta-1,4-galactosyltransferase II predicts poor prognosis of patients with non-metastatic clear-cell renal cell carcinoma.Charge and Polarity Preferences for N-Glycosylation: A Genome-Wide In Silico Study and Its Implications Regarding Constitutive Proliferation and Adhesion of Carcinoma Cells.The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance.Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acidsO-GlcNAc: A Sweetheart of the Cell Cycle and DNA Damage Response
P2860
Q26744538-10ECF9C2-45F2-48D8-AE8B-72564A1670BDQ26752391-47609E7A-1434-4BA4-AABB-C3E651C8B433Q28071108-4D90226F-B697-4B36-853B-3C280EECD0CDQ35982371-70BB7DFF-0753-46BF-80DB-1B94D10FF193Q36110548-3713CAEE-52FF-4269-90CE-85DAC6E44FA7Q36164375-3BE436DB-5036-4048-970E-039690BB7091Q36501284-D05BE17D-281B-4AD1-BD7A-E254FD09F5DCQ37437526-4CE2E68B-F97B-4A79-870E-C6F5963B967AQ37519435-D6B333D4-1BC6-4909-949E-0EB8BC4C8039Q37564743-B199C315-892F-497F-A512-9272DF15AD89Q37619873-91219DEC-B739-462C-92FC-6A5BE3FF34E0Q37745961-E4979FE1-C045-4080-8387-80104A130724Q38758695-109297C8-58BC-4836-AB8C-3A0663B6BF7EQ38774452-044351BF-499F-4C42-A722-3CE083D2CF45Q38968841-680E8187-0F14-471C-A5D7-9D72C09C0A45Q41366826-7F3795F6-3C52-4B28-974D-40D25E62E34CQ42339288-45E8108D-1CB8-4EA0-BD5F-0453E3F066D3Q47785877-DC677617-415F-416F-89F4-953ED682FA35Q49185043-D1F8C9AB-96A8-4EFB-9D44-7A2984B179AFQ50098159-EFCA5680-1082-4681-9B75-ED701D86F288Q51743298-488FD0F8-90A5-4941-9194-3BC72658E58DQ52902527-8405A0A0-38F4-4BCA-B00C-791130BC8B70Q54985550-FC197BA1-C9E1-40B2-9A6B-B3936B541E2CQ55101661-A2B3514E-09E4-4A50-BAB0-95D6ACA2FA9CQ57169347-E6E7A29A-146B-4F72-8A90-F8558372FF63Q57174136-A430C6AF-BBE8-4693-A262-38296214D9EB
P2860
Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Biosynthetic Machinery Involve ...... loping of Drugs Against Cancer
@en
type
label
Biosynthetic Machinery Involve ...... loping of Drugs Against Cancer
@en
prefLabel
Biosynthetic Machinery Involve ...... loping of Drugs Against Cancer
@en
P2093
P2860
P356
P1476
Biosynthetic Machinery Involve ...... loping of Drugs Against Cancer
@en
P2093
Adriane Regina Todeschini
Andréia Vasconcelos-Dos-Santos
Isadora A Oliveira
Miguel Clodomiro Lucena
Natalia Rodrigues Mantuano
P2860
P356
10.3389/FONC.2015.00138
P577
2015-06-25T00:00:00Z